| Mandy Sue Harting, MD | |
|
9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380-3181 | |
| (281) 363-5050 | |
| (281) 296-2072 |
| Full Name | Mandy Sue Harting |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 20 Years |
| Location | 9303 Pinecroft Dr, The Woodlands, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437324480 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Woodlands Dermatology Associates Pa | 0042202947 | 10 |
News Archive
An initial Congressional Budget Office estimate of a version of health reform legislation favored by House liberals puts the price-tag within reach of President Obama's stated $900 billion limit for the overhaul, The Washington Post reports.
InComm, a leading prepaid product and transaction services company, announced today that it has acquired Medagate Corporation, the company that powers OTCNetwork, the only national closed loop over-the-counter (OTC) healthcare benefits payments platform.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
Etoposide plus cisplatin, given alongside accelerated hyperfractionated thoracic radiotherapy, remains the gold standard regimen for patients with limited-stage small-cell lung cancer, Japanese researchers say.
National Mentor Holdings, Inc. today announced its financial results for the third quarter ended June 30, 2010.
› Verified 5 days ago
| Entity Name | The Woodlands Dermatology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619919958 PECOS PAC ID: 0042202947 Enrollment ID: O20040331001445 |
News Archive
An initial Congressional Budget Office estimate of a version of health reform legislation favored by House liberals puts the price-tag within reach of President Obama's stated $900 billion limit for the overhaul, The Washington Post reports.
InComm, a leading prepaid product and transaction services company, announced today that it has acquired Medagate Corporation, the company that powers OTCNetwork, the only national closed loop over-the-counter (OTC) healthcare benefits payments platform.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
Etoposide plus cisplatin, given alongside accelerated hyperfractionated thoracic radiotherapy, remains the gold standard regimen for patients with limited-stage small-cell lung cancer, Japanese researchers say.
National Mentor Holdings, Inc. today announced its financial results for the third quarter ended June 30, 2010.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mandy Sue Harting, MD 9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380-3181 Ph: (281) 363-5050 | Mandy Sue Harting, MD 9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380-3181 Ph: (281) 363-5050 |
News Archive
An initial Congressional Budget Office estimate of a version of health reform legislation favored by House liberals puts the price-tag within reach of President Obama's stated $900 billion limit for the overhaul, The Washington Post reports.
InComm, a leading prepaid product and transaction services company, announced today that it has acquired Medagate Corporation, the company that powers OTCNetwork, the only national closed loop over-the-counter (OTC) healthcare benefits payments platform.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
Etoposide plus cisplatin, given alongside accelerated hyperfractionated thoracic radiotherapy, remains the gold standard regimen for patients with limited-stage small-cell lung cancer, Japanese researchers say.
National Mentor Holdings, Inc. today announced its financial results for the third quarter ended June 30, 2010.
› Verified 5 days ago
Dr. Andrew Decrescenzo, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9303 Pinecroft Dr Ste 310, The Woodlands, TX 77380 Phone: 281-363-5050 Fax: 281-363-5020 | |
Amy C Bumgardner, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380 Phone: 281-363-5050 | |
Stephen B Tucker, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1055 Evergreen Cir, The Woodlands, TX 77380 Phone: 281-367-9110 Fax: 832-813-0344 | |
Dr. Brent Andrew Shook, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8850 Six Pines Drive, Suite 290, The Woodlands, TX 77380 Phone: 281-364-8844 Fax: 281-364-8833 | |
Dr. Haneol Sam Jeong, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9303 Pinecraft Drive, Suite 150, The Woodlands, TX 77380 Phone: 281-363-5050 Fax: 281-363-5020 | |
Dr. Nhan Minh Nguyen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 17183 I 45 Suite 510, The Woodlands, TX 77385 Phone: 713-791-9966 |